Terumo Neuro
Scafford Serron joined MicroVention in 2021 as Vice President, Global Quality. Scafford has worked in pharmaceuticals and medical devices and has 20 plus years of experience in the medical devices industry in various areas such as Cardiovascular, Cardiopulmonary, Neuromodulation, and Dental. He has worked for organizations like Edwards Lifesciences, Danaher, JenaValve, Envista, and Livanova, with responsibilities for multiple sites across the globe. Scafford holds a Bachelor's and Master's degree in Chemistry from the University of Bombay (Mumbai) and a Master's and Ph.D. in Chemistry from the University of New Orleans.
This person is not in any offices
Terumo Neuro
1 followers
A global leader in neurovascular innovation, MicroVention is now Terumo Neuro. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care. We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to meaningfully advance both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in California, Terumo Neuro products are sold in more than seventy countries through a direct sales organization as well as strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California, and San José, Costa Rica.